| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.21▼ | 1.20▲ | 1.21▼ | 1.27▼ | 1.27▼ |
| MA10 | 1.21▲ | 1.22▼ | 1.23▼ | 1.24▼ | 1.32▼ |
| MA20 | 1.20▲ | 1.25▼ | 1.25▼ | 1.26▼ | 1.62▼ |
| MA50 | 1.23▼ | 1.25▼ | 1.25▼ | 1.38▼ | 1.98▼ |
| MA100 | 1.24▼ | 1.27▼ | 1.27▼ | 1.66▼ | 2.42▼ |
| MA200 | 1.27▼ | 1.27▼ | 1.36▼ | 2.07▼ | 2.17▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.007▼ | -0.008▼ | 0.008▲ | -0.033▼ |
| RSI | 47.021▼ | 41.706▼ | 41.654▼ | 41.971▼ | 36.656▼ |
| STOCH | 83.333▲ | 3.030▼ | 5.208▼ | 51.935 | 24.795 |
| WILL %R | 0.000▲ | -91.667▼ | -91.667▼ | -75.000▼ | -84.375▼ |
| CCI | 77.778 | -65.214 | -98.259 | -123.287▼ | -63.698 |
|
Tuesday, February 10, 2026 05:45 AM
Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, today announced receipt of $12.2 Million in net cash proceeds from the sale of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/02/26 | 1.20 | 1.21 | 1.20 | 1.21 | 12,909 |
| 11/02/26 | 1.27 | 1.27 | 1.215 | 1.25 | 32,494 |
| 10/02/26 | 1.25 | 1.32 | 1.25 | 1.27 | 74,384 |
| 09/02/26 | 1.30 | 1.33 | 1.274 | 1.30 | 10,654 |
| 06/02/26 | 1.21 | 1.31 | 1.21 | 1.30 | 16,480 |
| 05/02/26 | 1.24 | 1.24 | 1.17 | 1.17 | 26,482 |
| 04/02/26 | 1.265 | 1.30 | 1.20 | 1.20 | 54,615 |
| 03/02/26 | 1.25 | 1.2532 | 1.20 | 1.23 | 56,315 |
| 02/02/26 | 1.20 | 1.28 | 1.20 | 1.26 | 16,826 |
| 30/01/26 | 1.25 | 1.29 | 1.19 | 1.22 | 54,840 |
|
|
||||
|
|
||||
|
|